Liepold; Bernd
Patent Applications and Registrations
Patent applications and USPTO patent grants for Liepold; Bernd.The latest application filed is for "pharmaceutical dosage form for oral administration of a bcl 2 family inhibitor".
Company Profile
7.31.39
- Liepold; Bernd - Dossenheim DE
- Liepold; Bernd - Heidelberg DE
- Liepold, Bernd - Mannheim DE
Patent Activity
| Patent | Date |
|---|---|
| Pharmaceutical Dosage Form For Oral Administration Of A Bcl 2 Family Inhibitor App 20220110951 - Henzel; Claudia ; et al. | 2022-04-14 |
| Pharmaceutical Dosage Form For Oral Administration Of A Bcl 2 Family Inhibitor App 20210093649 - Packhaeuser; Claudia ; et al. | 2021-04-01 |
| Production of dosage forms comprising a solid dispersion of a microcrystalline agent Grant 10,653,625 - Rosenberg , et al. | 2020-05-19 |
| Solid retard formulations based on solid dispersions Grant 10,463,739 - Berndl , et al. No | 2019-11-05 |
| Pharmaceutical Dosage Form For Oral Administration Of A Bcl 2 Family Inhibitor App 20190269704 - Packhaeuser; Claudia ; et al. | 2019-09-05 |
| Solid antiviral dosage forms Grant 10,105,365 - Miller , et al. October 23, 2 | 2018-10-23 |
| Solid Antiviral Dosage Forms App 20170368066 - Miller; Jonathan M. ; et al. | 2017-12-28 |
| Solid antiviral dosage forms Grant 9,744,170 - Miller , et al. August 29, 2 | 2017-08-29 |
| Pharmaceutical Dosage Form For Oral Administration Of A Bcl-2 Family Inhibitor App 20170189426 - Packhaeuser; Claudia ; et al. | 2017-07-06 |
| Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitor Grant 9,642,796 - Packhaeuser , et al. May 9, 2 | 2017-05-09 |
| Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same Grant 9,616,130 - Rosenberg , et al. April 11, 2 | 2017-04-11 |
| Test solvent for evaluating the compatibility of biologically active substances and graft copolymers Grant 9,594,073 - Breitenbach , et al. March 14, 2 | 2017-03-14 |
| Pharmaceutical dosage form comprising polymeric carrier composition Grant 9,402,909 - Liepold , et al. August 2, 2 | 2016-08-02 |
| Solid Antiviral Dosage Forms App 20160199374 - Miller; Jonathan M. ; et al. | 2016-07-14 |
| Solid antiviral dosage forms Grant 9,333,204 - Miller , et al. May 10, 2 | 2016-05-10 |
| Pharmaceutically Acceptable Solubilizing Composition and Pharmaceutical Dosage Form Containing Same App 20150314000 - Rosenberg; Jorg ; et al. | 2015-11-05 |
| Solid Antiviral Dosage Forms App 20150258093 - Miller; Jonathan M. ; et al. | 2015-09-17 |
| Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same Grant 9,078,921 - Rosenberg , et al. July 14, 2 | 2015-07-14 |
| Delivery system for sustained release of a calcium-channel blocking agent Grant 9,060,986 - Breitenbach , et al. June 23, 2 | 2015-06-23 |
| Solid Pharmaceutical Compositions App 20150141351 - Durak; Faith ; et al. | 2015-05-21 |
| Solid Retard Formulations Based On Solid Dispersions App 20140296336 - Berndl; Gunther ; et al. | 2014-10-02 |
| Pharmaceutical Dosage Form Comprising Polymeric Carrier Composition App 20140200278 - Liepold; Bernd ; et al. | 2014-07-17 |
| Solid Pharmaceutical Dosage Form App 20140179721 - Rosenberg; Joerg ; et al. | 2014-06-26 |
| Solid Compositions App 20140171481 - Liepold; Bernd ; et al. | 2014-06-19 |
| Solid pharmaceutical dosage form Grant 8,691,878 - Rosenberg , et al. April 8, 2 | 2014-04-08 |
| Solid compositions Grant 8,686,026 - Liepold , et al. April 1, 2 | 2014-04-01 |
| Test Solvent For Evaluating The Compatibility Of Biologically Active Substances And Graft Copolymers App 20130118238 - Breitenbach; Jorg ; et al. | 2013-05-16 |
| Solid Pharmaceutical Dosage Form App 20130072508 - Rosenberg; Joerg ; et al. | 2013-03-21 |
| Solid pharmaceutical dosage form Grant 8,399,015 - Rosenberg , et al. March 19, 2 | 2013-03-19 |
| Solid pharmaceutical dosage formulation Grant 8,377,952 - Rosenberg , et al. February 19, 2 | 2013-02-19 |
| Solid Pharmaceutical Dosage Formulation App 20130004578 - Rosenberg; Jorg ; et al. | 2013-01-03 |
| Solid pharmaceutical dosage form Grant 8,333,990 - Rosenberg , et al. December 18, 2 | 2012-12-18 |
| Solid pharmaceutical dosage form Grant 8,309,613 - Rosenberg , et al. November 13, 2 | 2012-11-13 |
| Test system for evaluating the compatibility of biologically active substances with copolymers Grant 8,293,374 - Breitenbach , et al. October 23, 2 | 2012-10-23 |
| Solid Compositions App 20120258909 - Liepold; Bernd ; et al. | 2012-10-11 |
| Delivery System For Sustained Release Of A Calcium-channel Blocking Agent App 20120252851 - Breitenbach; Jorg ; et al. | 2012-10-04 |
| Solid pharmaceutical dosage form Grant 8,268,349 - Rosenberg , et al. September 18, 2 | 2012-09-18 |
| Solid Pharmaceutical Dosage Form App 20120202858 - Rosenberg; Joerg ; et al. | 2012-08-09 |
| Solid Pharmaceutical Dosage Form App 20120022089 - Rosenberg; Joerg ; et al. | 2012-01-26 |
| Solid Compositions App 20110312973 - Liepold; Bernd ; et al. | 2011-12-22 |
| Solid pharmaceutical dosage form Grant 8,025,899 - Berndl , et al. September 27, 2 | 2011-09-27 |
| Pharmaceutical Dosage Form Comprising Polymeric Carrier Composition App 20110182891 - Liepold; Bernd ; et al. | 2011-07-28 |
| Solid Pharmaceutical Dosage Form App 20110015216 - Berndl; Gunther ; et al. | 2011-01-20 |
| Solid Pharmaceutical Dosage Form App 20110008430 - Rosenberg; Jorg ; et al. | 2011-01-13 |
| Pharmaceutical Dosage Form For Oral Administration Of A Bcl 2 Family Inhibitor App 20100310648 - Packhaeuser; Claudia ; et al. | 2010-12-09 |
| Formulation For Oral Administration Of Apoptosis Promoter App 20100297194 - Catron; Nathaniel ; et al. | 2010-11-25 |
| Pharmaceutically Acceptable Solubilizing Composition And Pharmaceutical Dosage Form Containing Same App 20100247635 - Rosenberg; Jorg ; et al. | 2010-09-30 |
| Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor App 20100143459 - Liepold; Bernd ; et al. | 2010-06-10 |
| Production of Dosage Forms Comprising a Solid Dispersion of a Microcrystalline Agent App 20090012184 - Rosenberg; Jorg ; et al. | 2009-01-08 |
| Solid Pharmaceutical Dosage Formulation App 20080299203 - Rosenberg; Joerg ; et al. | 2008-12-04 |
| Solid Pharmaceutical Dosage Formulations App 20080181948 - Berndl; Gunther ; et al. | 2008-07-31 |
| Solid Pharmaceutical Dosage Form App 20070249643 - Rosenberg; Joerg ; et al. | 2007-10-25 |
| Solid pharmaceutical dosage formulation App 20050143404 - Rosenberg, Joerg ; et al. | 2005-06-30 |
| Test system for evaluating the compatibility of biologically active substances with copolymers App 20050131054 - Breitenbach, Joerg ; et al. | 2005-06-16 |
| Solid pharmaceutical dosage form App 20050084529 - Rosenberg, Joerg ; et al. | 2005-04-21 |
| Solid pharmaceutical dosage form App 20050048112 - Breitenbach, Jorg ; et al. | 2005-03-03 |
| Mechanically stable pharmaceutical presentations form containing liquid or semisolid surface-active substances Grant 6,599,528 - Rosenberg , et al. July 29, 2 | 2003-07-29 |
| Test system for characterizing the compatibility of bioactive substances and polyvinylpyrrolidone Grant 6,599,931 - Breitenbach , et al. July 29, 2 | 2003-07-29 |
| Formulation based on lipoic acid, process for its production and the use of this formulation for oral administration of lipoic acid App 20020151578 - Breitenbach, Jorg ; et al. | 2002-10-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 